不孕症治疗服务市场规模、份额、趋势和预测：按不孕症病因、治疗方法、服务、最终用户和地区划分，2026-2034 年

2025年全球生育服务市场规模为519亿美元。展望未来，IMARC集团预测，该市场将在2026年至2034年间以12.15%的复合年增长率成长，到2034年达到1502亿美元。目前，亚太地区是该市场的主要驱动力，预计到2025年将占据30%的市场。推动这一增长的因素包括人口基数不断扩大、生活方式相关不孕症和延迟生育率上升、收入水平提高使得更多人能够获得生殖医学服务，以及专业生育诊所网络不断扩展。所有这些因素都促进了亚太地区生育服务市场份额的扩大。

已开发国家和开发中国家不孕症病例的不断增加，推动了生育服务市场的成长，促使更多个人和夫妇寻求生育服务。由于生育年龄延迟、生活方式相关的健康问题以及生殖系统疾病病例的增加等因素，全球患者数量正在稳步增长。卵子冷冻和代孕等生育服务的接受度不断提高，以及政府强制推行的保险覆盖，使得人们更容易获得生育服务。生育诊所的增加、冷冻保存技术和基因筛检的进步，以及人们健康意识的提高，都是推动生育服务市场发展的因素。

由于多种因素，美国正崛起为生育服务市场的重要区域。凭藉世界一流的医疗保健基础设施、训练有素的生殖内分泌专家以及完善的认证生育中心网络，美国拥有全球最先进、最成熟的生殖健康生态系统之一。 2025年10月，美国政府宣布了倡议，旨在降低体外受精（IVF）药物的成本并扩大生育保险的覆盖范围，包括独立的IVF福利和药物折扣。专业专业延迟生育的趋势、同性伴侣建立家庭数量的增加以及与生活方式和环境因素相关的生育率上升，都推动了市场对生育服务的巨大需求。此外，雇主提供的生育福利也日益普遍，越来越多的公司将生育保险纳入员工健康保险计划，以吸引和留住人才。

不孕症治疗服务市场趋势

全球不孕不育率上升

不孕症盛行率的上升是推动生育治疗服务市场发展的关键因素。受孕延迟、久坐的生活方式、环境污染以及生殖健康问题发病率的增加，都加剧了全球不孕症负担。世界卫生组织（世卫组织）于2025年11月发布了首个全球不孕症指南，指出约六分之一的育龄妇女受到不孕症的影响，凸显了不孕症作为一项重大公共卫生问题的严重性，以及扩大预防、诊断和治疗服务覆盖范围的必要性。随着许多国家的性生活频率和生育率的上升，对辅助生殖技术的需求持续强劲。为了应对这一问题，各国政府和卫生组织正在扩大宣传宣传活动，并为治疗津贴。不孕症作为一种合法疾病的日益被认可，使得寻求治疗变得更加普遍，扩大了患者群体，并确保了长期的市场需求。

生殖医学的技术进步

快速的技术进步正在改变生殖医学，使辅助生殖技术更有效率和个人化。胚胎着床前遗传学检测、胚胎选择演算法、延时成像和冷冻保存技术的进步显着提高了手术成功率。人工智慧 (AI) 在胚胎评估中的应用，使得临床决策更加数据驱动，从而改善了患者的治疗效果。 2025 年 9 月，Fairtility 的人工智慧胚胎评估平台 CHLOE 获得美国食品药物管理局 (FDA) 的核准。这是美国首个核准的同种异体设备，能够使临床体外受精 (IVF) 中的胚胎评估更加客观和数据驱动。小型化的实验室系统和自动化工具提高了手术的准确性，同时降低了营运成本。新的卵巢刺激通讯协定和改良的培养基也进一步提高了出生率。这些发展正在推动医疗和生物技术领域的投资成长，随着患者对实证、技术先进的生殖解决方案的需求日益增长，这些发展对生育服务的市场前景产生了积极影响。

社会接受度和意识的提高

文化态度的转变正在对全球生育服务的扩张起到变革性作用。生育治疗曾一度饱受污名化，如今已被广泛认可为合法且必要的医疗干预措施。媒体通报和公开讨论使生殖健康议题不再是人们关注的焦点，鼓励个人和夫妻积极寻求帮助。 2025年3月，英国健康与胚胎管理局（HFEA）报告称，约72%的生育患者对其最近一次治疗感到满意。这反映出人们对生育治疗的信心增强，以及对治疗结果更开放的态度。单亲家庭的兴起和LGBTQ+家庭的壮大正在扩大生育服务的用户群体，并使需求模式更加多元化。医疗服务提供者和支持团体持续进行有针对性的宣传活动，普及生殖健康和生育力保存方面的知识。生育服务市场的这些趋势反映了社会的根本性变革，并支撑着全球对全面生育照护日益增长的需求。

目录

第一章：序言

第二章：调查方法

• 调查目的
• 相关利益者
• 数据来源
  • 主要讯息
  • 次要讯息
• 市场估值
  • 自下而上的方法
  • 自上而下的方法
• 调查方法

第三章执行摘要

第四章：引言

第五章：全球不孕症治疗服务市场

• 市场概览
• 市场表现
• 新冠疫情的影响
• 市场区隔：依不孕不育原因分类
• 市场区隔：按治疗类型
• 市场区隔：依服务分类
• 市场区隔：依最终用户划分
• 市场区隔：按地区
• 市场预测

第六章 市场区隔：依不孕症病因分类

• 男性不孕
• 女性不孕症

第七章 市场区隔：依治疗方式划分

• 体外卵细胞质内单一精虫显微注射术（IVF with ICSI）
• 代孕
• 体外受精（卵细胞质内单一精虫显微注射术）
• 子宫内人工授精（IUI）
• 其他的

第八章 市场区隔：依服务分类

• 非活体捐赠者
• 冷冻非捐赠者
• 卵子和胚胎的保存
• 活体捐赠者
• 冷冻捐赠者

第九章 市场区隔：依最终用户划分

• 不孕症治疗诊所
• 医院
• 外科中心
• 临床研究机构
• 冷冻保存库

第十章 市场区隔：依地区划分

• 欧洲
• 北美洲
• 亚太地区
• 中东和非洲
• 拉丁美洲

第十一章 SWOT 分析

第十二章：价值链分析

第十三章：波特五力分析

第十四章：价格分析

第十五章 竞争格局

• 市场结构
• 主要企业
• 主要企业简介
  • Instituto Bernabeu Group
  • INVO Bioscience, Inc.
  • Monash IVF Group
  • Apollo Hospitals Enterprise Ltd.
  • CARE Fertility Group Ltd.
  • Carolinas Fertility Institute
  • Genea Limited
  • The Cooper Companies, Inc.
  • Virtus Health Group
  • Vitrolife Sweden AB
  • The Johns Hopkins Health System Corporation
  • Medicover AB（publ）
  • OvaScience, Inc.
  • Progyny, Inc.
  • Xytex Corporation

The global fertility services market size was valued at USD 51.9 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 150.2 Billion by 2034, exhibiting a CAGR of 12.15% from 2026-2034. Asia Pacific currently dominates the market, holding a market share of 30% in 2025. The region benefits from its expanding population base, increasing rates of infertility attributed to lifestyle-related factors and delayed family planning, rising income levels facilitating access to reproductive healthcare, and a growing network of specialized fertility clinics, all contributing to the Asia Pacific fertility services market share.

The fertility services market growth is driven by the rising cases of infertility in both developed and developing nations, thus encouraging more individuals and couples to turn to fertility services. The rising number of late pregnancies, lifestyle-related health problems, and the growing number of cases of reproductive disorders are steadily increasing the global patient base. The growing acceptance of fertility services such as egg freezing and surrogacy, as well as government insurance mandates, are making fertility services more accessible. The growing number of fertility clinics, advancements in cryopreservation and genetic screening, and growing awareness about healthcare are all factors that are driving the fertility services market.

The United States has emerged as a major region in the fertility services market owing to many factors. The country hosts one of the most advanced and well-established reproductive healthcare ecosystems globally, supported by world-class medical infrastructure, highly trained reproductive endocrinologists, and a robust network of accredited fertility centers. In October 2025, the U.S. government announced a policy initiative to lower the cost of in-vitro fertilization (IVF) medications and expand access to fertility coverage, including standalone IVF benefits and discounted drugs. Significant demand is driven by the growing trend of delayed parenthood among working professionals, increasing same-sex couple family formation, and rising infertility rates linked to lifestyle and environmental factors. Additionally, employer-sponsored fertility benefits have become increasingly commonplace, with a growing number of corporations including fertility coverage in employee health plans to attract and retain talent.

FERTILITY SERVICES MARKET TRENDS:

Rising Prevalence of Infertility Worldwide

The rising prevalence of infertility is a critical driver shaping the fertility services market. Postponement of childbearing, sedentary lifestyles, environmental pollutant exposure, and growing incidences of reproductive health disorders are collectively expanding the infertility burden across global populations. According to the World Health Organization's first global guideline on infertility released in November 2025, infertility affects about one in six people of reproductive age, highlighting its scale as a major public health issue and need for wider access to prevention, diagnosis, and treatment. Both male and female infertility rates have trended upward in numerous countries, sustaining consistent demand for medically assisted reproduction. In response to the issue, governments and health organizations have expanded awareness campaigns and subsidized treatments. The increasing acceptance of infertility as a legitimate medical condition has normalized seeking treatment, which has expanded the pool of patients and ensured long-term market demand.

Technological Advancements in Reproductive Medicine

Rapid technological innovation is transforming reproductive medicine, making assisted reproduction more effective and personalized. Advancements in preimplantation genetic testing, embryo selection algorithms, time-lapse imaging, and cryopreservation methods have significantly improved procedural success rates. Artificial intelligence applications in embryo evaluation enable more data-driven clinical decisions, enhancing patient outcomes. In September 2025, Fairtility received FDA clearance for its CHLOE AI-powered embryo assessment platform, the first such device approved in the United States, enabling more objective, data-driven embryo evaluation in clinical IVF practice. Miniaturized laboratory systems and automation tools are improving procedural precision while reducing operational costs. Novel ovarian stimulation protocols and improved culture media are further contributing to higher live birth rates. These developments are attracting growing healthcare and biotechnology investments, positively influencing the fertility services market outlook as patients increasingly prefer evidence-based, technologically advanced reproductive care solutions.

Growing Social Acceptance and Awareness

Shifting cultural attitudes are playing a transformative role in expanding the utilization of fertility services globally. Historically stigmatized, fertility treatments are now widely regarded as legitimate and medically necessary interventions. Media representation and open public discourse have normalized reproductive health challenges, encouraging individuals and couples to proactively seek assistance. In March 2025, the UK's Human Fertilisation and Embryology Authority (HFEA) reported that nearly 72% of fertility patients were satisfied with their most recent treatment, reflecting growing comfort with fertility care and openness about outcomes. The rise of single parenthood by choice and LGBTQ+ family formation has broadened the demographic of fertility services users, diversifying demand patterns. Healthcare providers and advocacy organizations continue launching targeted awareness initiatives around reproductive health and fertility preservation options. These evolving fertility services market trends reflect a fundamental societal shift, sustaining growing demand for comprehensive fertility interventions worldwide.

FERTILITY SERVICES INDUSTRY SEGMENTATION:

Analysis by Cause of Infertility:

• Male Infertility
• Female Infertility

Female infertility contributes 62% to the market share. Female infertility can be described as a broad spectrum of reproductive disorders that impact a woman's ability to reproduce or maintain a pregnancy to term. The leading causes of female infertility include ovulatory dysfunction, tubal factor, uterine abnormalities, and conditions such as polycystic ovary syndrome, endometriosis, and premature ovarian failure. Compared to male infertility, the diagnostic and therapeutic strategies for female infertility are more complex and subtle, requiring a variety of therapies from hormonal to surgical and reproductive assistive therapies. The clinical complexity and associated burden of female reproductive disorders contribute significantly to the total demand for fertility care, from ovulation induction to in vitro fertilization and egg donation. Moreover, egg freezing for fertility preservation has emerged as a new market that has been expanding rapidly over the last few years, as women are now empowered to control their reproductive life plan in the context of delayed reproduction.

Analysis by Procedure:

• In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
• Surrogacy
• In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
• Intrauterine Insemination (IUI)
• Others

In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI) currently dominates the market with a share of 35%. This technique involves the injection of a single sperm directly into a mature egg, providing a highly targeted and effective approach for couples struggling with severe male factor infertility or unexplained infertility after failed conventional IVF cycles. Due to its proven efficacy and high fertilization success rates, combined with its compatibility with preimplantation genetic testing, IVF with ICSI has become the method of choice in the most advanced clinics worldwide for the selection of chromosomally normal embryos prior to uterine transfer. Sperm selection by MAC (magnetic-activated cell sorting) technique is used in men who have poor sperm morphology and/or low sperm counts. It is also useful in cases when fertilization fails in dietary procedures. Constant enhancement of laboratory techniques, improvements in ovarian stimulation regimens and the increased expertise of reproductive practitioners together are responsible for the success of ICSI, thereby making it the leader in the fertility techniques market.

Analysis by Service:

• Fresh Non-Donor
• Frozen Non-Donor
• Egg and Embryo Banking
• Fresh Donor
• Frozen Donor

Fresh non-donor dominates the market, with a share of 30%. Fresh non-donor services involve the use of a patient's own freshly retrieved eggs and partner-provided sperm to create embryos for immediate transfer, making it the most widely utilized fertility service pathway. This approach is preferred by couples seeking a biologically connected parenthood option without reliance on donor gametes, and it remains the first-line treatment option in most fertility clinics globally. The fresh non-donor cycle is favored for its natural approach, immediate embryo transfer capability, and the avoidance of complexities associated with cryopreservation protocols in uncomplicated cases. Its widespread adoption across both public and private fertility settings, combined with high patient familiarity and physician comfort with the procedure, sustains its leading market position. The growing volume of IVF and ICSI cycles being performed globally, along with favorable clinical guidelines recommending fresh transfers in appropriate candidates, reinforces the prominence of this segment within the broader fertility services market forecast.

Analysis by End-User:

• Fertility Clinics
• Hospitals
• Surgical Centres
• Clinical Research Institutes
• Cryobanks

Fertility clinics represent the leading segment, with a market share of 41%. These are specially designed facilities that are equipped with the latest reproductive laboratories, diagnostic facilities, and staff specifically trained to deal with infertility evaluation and management. Fertility clinics provide an integrated service delivery that encompasses consultation, hormonal analysis, ultrasound follow-up, egg retrieval procedures, embryology laboratory facilities, embryo transfer, and follow-up care in a single setting. The concentration of expertise, infrastructure, and patient focus makes fertility clinics the point of choice for patients seeking assisted reproductive technology services. In November 2025, INVO Fertility, Inc. announced plans to acquire Indiana-based Family Beginnings, expanding its national clinic network to meet rising patient demand and reflecting ongoing consolidation in the fertility sector. Many leading clinics have also established partnerships with genetic testing laboratories and cryobanks, enabling seamless integration of preimplantation genetic testing and fertility preservation into their service offerings.

Regional Analysis:

• Europe
• North America
• Asia Pacific
• Middle East and Africa
• Latin America

Asia Pacific, accounting for 30% of the share, enjoys the leading position in the market. The region's dominance is underpinned by several interconnected factors that collectively drive robust demand for fertility services across its diverse economies. The region includes some of the most populated countries in the world, such as China, India, Japan, South Korea, and Australia, each with unique fertility service demand patterns influenced by demographic factors, healthcare policies, and cultural perceptions of assisted reproduction. The rapidly aging population in the East Asian economies, combined with the high prevalence of infertility in South Asian markets, provides a wide patient base. Government-backed fertility assistance initiatives, such as IVF cycle subsidies in Japan, Australia, and South Korea, have greatly enhanced the accessibility and affordability of fertility services. At the same time, the growing number of technologically advanced fertility centers and the rising medical tourism presence in countries like India and Thailand continue to enhance the fertility services capacity in the Asia Pacific region, making it the largest regional contributor to the global market.

KEY REGIONAL TAKEAWAYS:

North America Fertility Services Market Analysis

North America represents one of the most advanced and well-established regional markets for fertility services, driven by a combination of demographic shifts, technological leadership, and favorable policy environments. The region benefits from a high concentration of accredited fertility centers, sophisticated reproductive laboratory infrastructure, and a robust network of highly trained reproductive specialists dedicated to delivering comprehensive assisted reproductive care. Rising infertility prevalence linked to delayed childbearing, lifestyle-related health conditions, and increasing family formation among diverse demographics, including same-sex couples and single individuals, continues to expand the patient base significantly. Employer-sponsored fertility benefits and state-level insurance mandates have substantially improved treatment affordability and accessibility across broader population segments. The strong culture of innovation in reproductive medicine, combined with growing patient awareness, increasing investment in fertility technologies, and expanding clinic networks, reinforces North America's prominent and sustained position within the global fertility services market.

United States Fertility Services Market Analysis

The United States is the most advanced and mature fertility services market in the world, with a high level of concentration of accredited fertility centers, a complex fertility services ecosystem, and a well-established regulatory framework led by professional associations such as the Society for Assisted Reproductive Technology. The demand for fertility services in the United States is fueled by a combination of demographic and social trends, including the pervasive trend of delayed childbearing, the high prevalence of infertility in the general population, and the growing trend of family formation among same-sex couples. The availability of fertility benefits through employers has increased substantially, with an increasing number of Fortune 500 companies offering comprehensive fertility benefits as part of their employees' health benefits, making fertility treatments that were hitherto cost-prohibitive more accessible to patients. State-based insurance mandates requiring coverage for fertility diagnostics and treatments have also widened the pool of eligible patients and made fertility treatments more accessible. The culture of innovation in the United States reproductive medicine industry, along with high patient engagement, makes the United States the largest and most vibrant national fertility services market in the world.

Europe Fertility Services Market Analysis

Europe represents the second largest regional market for fertility services, supported by well-funded public healthcare systems in many member states and a long-established tradition of reproductive medicine research and clinical excellence. Countries such as Spain, Denmark, the Czech Republic, and the United Kingdom have positioned themselves as leading destinations for fertility treatments, attracting significant volumes of patients from both within Europe and internationally through medical tourism. In February 2025, Poland reinstated public funding for in-vitro fertilization (IVF), leading to its first IVF-conceived babies under the scheme and making all EU member states provide some level of public fertility treatment funding. The European fertility services landscape is characterized by a combination of publicly funded fertility treatment cycles and a thriving private clinic sector, with the balance varying considerably across different national healthcare systems. Regulatory frameworks governing donor anonymity, surrogacy, and embryo storage policies differ significantly across European jurisdictions, influencing patient cross-border movements and clinic specialization strategies.

Asia Pacific Fertility Services Market Analysis

The Asia Pacific has turned out to be the most rapidly growing market for fertility care. The growing demand for fertility care in the Asia Pacific is fueled by a number of factors, including the demographic trend, advancements in the healthcare infrastructure, and the changing attitudes of society towards fertility care. The rising incidence of infertility, due to late marriage and childbearing, environmental conditions, and lifestyle-related health issues, is increasing the patient base in the East and South Asian markets. Government support in Japan and South Korea to provide subsidies for fertility care is actively working to overcome the cost constraints and fuel the demand. The rapid development of a network of fertility clinics and the rising trend of medical tourism in India and Thailand is further strengthening the competitiveness of the Asia Pacific market in the global arena.

Latin America Fertility Services Market Analysis

Latin America is a steadily expanding market for fertility care, fueled by the growing awareness of infertility, private investments in the healthcare sector, and favorable medical tourism trends. Brazil, Mexico, Colombia, and Argentina have become the hubs for fertility care in Latin America, providing affordable fertility treatments that lure local as well as foreign patients. The rising levels of urbanization, changing lifestyles, and postponement of parenthood are contributing to the rising incidence of infertility in Latin America, which in turn is fueling the demand for various fertility treatments. Although fertility care is not easily accessible in rural and lower socioeconomic settings due to cost considerations, the increasing development of private fertility centers in major cities is slowly bridging the gap in fertility treatment accessibility in Latin America.

Middle East and Africa Fertility Services Market Analysis

The Middle East and Africa represent an emerging market for fertility services, characterized by significant growth potential amid evolving healthcare infrastructure and increasing social awareness of reproductive health. The high rates of infertility in the region, coupled with the cultural and religious values of family expansion, create a latent demand for fertility services. Countries such as the United Arab Emirates, Saudi Arabia, South Africa, and Israel have developed the infrastructure for advanced fertility clinics to attract patients from the region. Despite regulatory and cultural constraints that limit certain procedures such as surrogacy and gamete donation in some jurisdictions, the market continues to expand steadily, driven by rising healthcare spending, improving medical capabilities, and a growing population of treatment-seeking individuals.

COMPETITIVE LANDSCAPE:

The global fertility services market is moderately fragmented in terms of competitive intensity, with a combination of large integrated healthcare conglomerates, specialized fertility chain clinics, and standalone fertility clinics operating in different geographies. Market players are increasingly resorting to consolidation strategies, with private equity-funded acquisitions and mergers fueling the creation of large fertility clinic chains operating across several countries. Market leaders are diversifying their service offerings by investing in advanced reproductive technologies, lab infrastructure, and specialization, while at the same time expanding geographically to capitalize on high-growth fertility markets. Partnerships with genetic testing firms, embryo cryopreservation experts, and digital health platforms are also aiding players in providing more holistic and tech-enabled fertility solutions. Pricing competition and visibility of patient outcomes are reshaping the competitive environment, with patients increasingly using success rate data and reviews to select their fertility service provider. The industry is also facing challenges such as differences in regulations in various markets, a shortage of skilled reproductive specialists, and limited reimbursement in most regions.

The report provides a comprehensive analysis of the competitive landscape in the fertility services market with detailed profiles of all major companies, including:

• Instituto Bernabeu Group
• INVO Bioscience, Inc.
• Monash IVF Group
• Apollo Hospitals Enterprise Ltd.
• CARE Fertility Group Ltd.
• Carolinas Fertility Institute
• Genea Limited
• The Cooper Companies, Inc.
• Virtus Health Group
• Vitrolife Sweden AB
• The Johns Hopkins Health System Corporation
• Medicover AB (publ)
• OvaScience, Inc.
• Progyny, Inc.
• Xytex Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the fertility services market?

2. What is the future outlook of the fertility services market?

3. What are the key factors driving the fertility services market?

4. Which region accounts for the largest fertility services market share?

5. Which are the leading companies in the global fertility services market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Fertility Services Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Cause of Infertility
• 5.5 Market Breakup by Procedure
• 5.6 Market Breakup by Service
• 5.7 Market Breakup by End-User
• 5.8 Market Breakup by Region
• 5.9 Market Forecast

6 Market Breakup by Cause of Infertility

• 6.1 Male Infertility
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Female Infertility
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Procedure

• 7.1 In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Surrogacy
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Intrauterine Insemination (IUI)
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Service

• 8.1 Fresh Non-Donor
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Frozen Non-Donor
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Egg and Embryo Banking
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Fresh Donor
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Frozen Donor
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End-User

• 9.1 Fertility Clinics
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Hospitals
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Surgical Centres
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Clinical Research Institutes
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Cryobanks
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Market Breakup by Region

• 10.1 Europe
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 North America
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Asia Pacific
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Middle East and Africa
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 Latin America
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Instituto Bernabeu Group
  • 15.3.2 INVO Bioscience, Inc.
  • 15.3.3 Monash IVF Group
  • 15.3.4 Apollo Hospitals Enterprise Ltd.
  • 15.3.5 CARE Fertility Group Ltd.
  • 15.3.6 Carolinas Fertility Institute
  • 15.3.7 Genea Limited
  • 15.3.8 The Cooper Companies, Inc.
  • 15.3.9 Virtus Health Group
  • 15.3.10 Vitrolife Sweden AB
  • 15.3.11 The Johns Hopkins Health System Corporation
  • 15.3.12 Medicover AB (publ)
  • 15.3.13 OvaScience, Inc.
  • 15.3.14 Progyny, Inc.
  • 15.3.15 Xytex Corporation

List of Figures

• Figure 1: Global: Fertility Services Market: Major Drivers and Challenges
• Figure 2: Global: Fertility Services Market: Sales Value (in Billion USD), 2020-2025
• Figure 3: Global: Fertility Services Market: Breakup by Cause of Infertility (in %), 2025
• Figure 4: Global: Fertility Services Market: Breakup by Procedure (in %), 2025
• Figure 5: Global: Fertility Services Market: Breakup by Service (in %), 2025
• Figure 6: Global: Fertility Services Market: Breakup by End-User (in %), 2025
• Figure 7: Global: Fertility Services Market: Breakup by Region (in %), 2025
• Figure 8: Global: Fertility Services Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 9: Global: Fertility Services Industry: SWOT Analysis
• Figure 10: Global: Fertility Services Industry: Value Chain Analysis
• Figure 11: Global: Fertility Services Industry: Porter's Five Forces Analysis
• Figure 12: Global: Fertility Services (Male Infertility) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 13: Global: Fertility Services (Male Infertility) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 14: Global: Fertility Services (Female Infertility) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 15: Global: Fertility Services (Female Infertility) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 16: Global: Fertility Services (In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 17: Global: Fertility Services (In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 18: Global: Fertility Services (Surrogacy) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 19: Global: Fertility Services (Surrogacy) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 20: Global: Fertility Services In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI) ) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 21: Global: Fertility Services (In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI) ) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 22: Global: Fertility Services (Intrauterine Insemination (IUI)) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 23: Global: Fertility Services (Intrauterine Insemination (IUI)) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 24: Global: Fertility Services (Other Procedures) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 25: Global: Fertility Services (Other Procedures) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 26: Global: Fertility Services (Fresh Non-Donor) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 27: Global: Fertility Services (Fresh Non-Donor) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 28: Global: Fertility Services (Frozen Non-Donor) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 29: Global: Fertility Services (Frozen Non-Donor) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 30: Global: Fertility Services (Egg and Embryo Banking) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 31: Global: Fertility Services (Egg and Embryo Banking) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 32: Global: Fertility Services (Fresh Donor) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 33: Global: Fertility Services (Fresh Donor) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 34: Global: Fertility Services (Frozen Donor) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 35: Global: Fertility Services (Frozen Donor) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 36: Global: Fertility Services (Fertility Clinics) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 37: Global: Fertility Services (Fertility Clinics) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 38: Global: Fertility Services (Hospitals) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 39: Global: Fertility Services (Hospitals) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 40: Global: Fertility Services (Surgical Centres) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 41: Global: Fertility Services (Surgical Centres) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 42: Global: Fertility Services (Clinical Research Institutes) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 43: Global: Fertility Services (Clinical Research Institutes) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 44: Global: Fertility Services (Cryobanks) Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 45: Global: Fertility Services (Cryobanks) Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 46: Europe: Fertility Services Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 47: Europe: Fertility Services Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 48: North America: Fertility Services Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 49: North America: Fertility Services Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 50: Asia Pacific: Fertility Services Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 51: Asia Pacific: Fertility Services Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 52: Middle East and Africa: Fertility Services Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 53: Middle East and Africa: Fertility Services Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 54: Latin America: Fertility Services Market: Sales Value (in Billion USD), 2020 & 2025
• Figure 55: Latin America: Fertility Services Market Forecast: Sales Value (in Billion USD), 2026-2034

List of Tables

• Table 1: Global: Fertility Services Market: Key Industry Highlights, 2025 and 2034
• Table 2: Global: Fertility Services Market Forecast: Breakup by Cause of Infertility (in Billion USD), 2026-2034
• Table 3: Global: Fertility Services Market Forecast: Breakup by Procedure (in Billion USD), 2026-2034
• Table 4: Global: Fertility Services Market Forecast: Breakup by Service (in Billion USD), 2026-2034
• Table 5: Global: Fertility Services Market Forecast: Breakup by End-User (in Billion USD), 2026-2034
• Table 6: Global: Fertility Services Market Forecast: Breakup by Region (in Billion USD), 2026-2034
• Table 7: Global: Fertility Services Market: Competitive Structure
• Table 8: Global: Fertility Services Market: Key Players